332 related articles for article (PubMed ID: 26394796)
1. Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders.
Yamasue H
Psychiatry Clin Neurosci; 2016 Feb; 70(2):89-99. PubMed ID: 26394796
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin and Autism Spectrum Disorders.
Yamasue H; Domes G
Curr Top Behav Neurosci; 2018; 35():449-465. PubMed ID: 28766270
[TBL] [Abstract][Full Text] [Related]
3. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
4. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
Owada K; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Yassin W; Kushima I; Benner S; Ogawa N; Kawano N; Eriguchi Y; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H; Yamasue H
Brain; 2019 Jul; 142(7):2127-2136. PubMed ID: 31096266
[TBL] [Abstract][Full Text] [Related]
5. Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.
Alvares GA; Quintana DS; Whitehouse AJ
Autism Res; 2017 Jan; 10(1):25-41. PubMed ID: 27651096
[TBL] [Abstract][Full Text] [Related]
6. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.
Okamoto Y; Ishitobi M; Wada Y; Kosaka H
CNS Neurol Disord Drug Targets; 2016; 15(5):564-77. PubMed ID: 27071789
[TBL] [Abstract][Full Text] [Related]
8. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZ
Kitagawa K; Matsumura K; Baba M; Kondo M; Takemoto T; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
Mol Brain; 2021 Mar; 14(1):56. PubMed ID: 33726803
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
[TBL] [Abstract][Full Text] [Related]
10. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
11. The effects of oxytocin administration on individuals with ASD: Neuroimaging and behavioral evidence.
Baker E; Stavropoulos KKM
Prog Mol Biol Transl Sci; 2020; 173():209-238. PubMed ID: 32711811
[TBL] [Abstract][Full Text] [Related]
12. Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis.
Huang Y; Huang X; Ebstein RP; Yu R
Neurosci Biobehav Rev; 2021 Mar; 122():18-27. PubMed ID: 33400920
[TBL] [Abstract][Full Text] [Related]
13. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
[TBL] [Abstract][Full Text] [Related]
14. [The Possible Role of Oxytocin in Autism Spectrum Disorder].
Munesue T; Minabe Y
Seishin Shinkeigaku Zasshi; 2016; 118(6):399-409. PubMed ID: 30620499
[TBL] [Abstract][Full Text] [Related]
15. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth.
Anagnostou E; Soorya L; Brian J; Dupuis A; Mankad D; Smile S; Jacob S
Brain Res; 2014 Sep; 1580():188-98. PubMed ID: 24508578
[TBL] [Abstract][Full Text] [Related]
16. Adaptive coding of the value of social cues with oxytocin, an fMRI study in autism spectrum disorder.
Andari E; Richard N; Leboyer M; Sirigu A
Cortex; 2016 Mar; 76():79-88. PubMed ID: 26872344
[TBL] [Abstract][Full Text] [Related]
17. Restoring effects of oxytocin on the attentional preference for faces in autism.
Kanat M; Spenthof I; Riedel A; van Elst LT; Heinrichs M; Domes G
Transl Psychiatry; 2017 Apr; 7(4):e1097. PubMed ID: 28418399
[TBL] [Abstract][Full Text] [Related]
18. [Oxytocin in the treatment of the social deficits associated to autism spectrum disorders].
Cachafeiro-Espino C; Vale-Martínez AM
Rev Neurol; 2015 Nov; 61(9):421-8. PubMed ID: 26503318
[TBL] [Abstract][Full Text] [Related]
19. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effects of oxytocin in autism: Current status of the research].
Gauthier C; Doyen C; Amado I; Lôo H; Gaillard R
Encephale; 2016 Feb; 42(1):24-31. PubMed ID: 26797566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
